Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial. (2019)

First Author: Tsai JN
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-8587(19)30255-4

PubMed Identifier: 31447409

Publication URI: http://europepmc.org/abstract/MED/31447409

Type: Journal Article/Review

Volume: 7

Parent Publication: The lancet. Diabetes & endocrinology

Issue: 10

ISSN: 2213-8587